ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 164 filers reported holding ALLOGENE THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 2.03 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $68,576 | -31.4% | 21,633 | +7.5% | 0.00% | – |
Q2 2023 | $100,016 | +4.4% | 20,124 | +3.7% | 0.00% | – |
Q1 2023 | $95,826 | -31.3% | 19,398 | -12.5% | 0.00% | – |
Q4 2022 | $139,518 | -38.0% | 22,181 | +6.2% | 0.00% | -100.0% |
Q3 2022 | $225,000 | -7.4% | 20,884 | -2.2% | 0.00% | 0.0% |
Q2 2022 | $243,000 | -8.6% | 21,359 | -26.9% | 0.00% | 0.0% |
Q1 2022 | $266,000 | -51.5% | 29,221 | -20.5% | 0.00% | 0.0% |
Q4 2021 | $549,000 | -47.7% | 36,775 | -9.9% | 0.00% | -66.7% |
Q3 2021 | $1,050,000 | -11.5% | 40,837 | -10.2% | 0.00% | 0.0% |
Q2 2021 | $1,186,000 | -4.3% | 45,476 | +29.5% | 0.00% | -25.0% |
Q1 2021 | $1,239,000 | +41.1% | 35,111 | +1.0% | 0.00% | +33.3% |
Q4 2020 | $878,000 | -22.8% | 34,779 | +15.3% | 0.00% | -40.0% |
Q3 2020 | $1,137,000 | -4.0% | 30,152 | +9.0% | 0.01% | -16.7% |
Q2 2020 | $1,184,000 | +204.4% | 27,659 | +38.4% | 0.01% | +100.0% |
Q1 2020 | $389,000 | -54.4% | 19,992 | -39.1% | 0.00% | -25.0% |
Q4 2019 | $853,000 | – | 32,842 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Vida Ventures Advisors, LLC | 1,798,163 | $16,381,000 | 9.53% |
Wildcat Capital Management, LLC | 2,128,370 | $19,389,000 | 4.96% |
TPG GP A, LLC | 18,716,306 | $170,506,000 | 2.11% |
Pier Capital, LLC | 746,669 | $6,802,000 | 0.87% |
Coastal Bridge Advisors, LLC | 401,929 | $3,662,000 | 0.84% |
HARBOR CAPITAL ADVISORS, INC. | 92,755 | $845,000 | 0.40% |
Lombard Odier Asset Management (Switzerland) SA | 501,219 | $4,566,000 | 0.36% |
Navalign, LLC | 74,271 | $623,000 | 0.26% |
PDT Partners, LLC | 241,592 | $2,201,000 | 0.19% |
GSA CAPITAL PARTNERS LLP | 148,804 | $1,356,000 | 0.18% |